Gaohua L. Feng

Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

Journal: Molecular cancer

Published: March 13, 2025

A cilia-associated signature predicts resistance to anti-PD-1 immune checkpoint blockade therapy in lung adenocarcinoma.

A cilia-associated signature predicts resistance to anti-PD-1 immune checkpoint blockade therapy in lung adenocarcinoma.

Journal: Cancer cell international

Published: January 13, 2024

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 26, 2023

Advanced lung adenocarcinoma patient with EGFR exon 20 insertion benefits from high-dose furmonertinib for nine months after progression from mobocertinib: a case report.

Advanced lung adenocarcinoma patient with EGFR exon 20 insertion benefits from high-dose furmonertinib for nine months after progression from mobocertinib: a case report.

Journal: Annals of translational medicine

Published: January 12, 2022

Systematic Pan-Cancer Population-Based Analysis Reveals the Incidence and Prognosis of Lung Metastases at Diagnosis.

Systematic Pan-Cancer Population-Based Analysis Reveals the Incidence and Prognosis of Lung Metastases at Diagnosis.

Journal: Journal of oncology

Published: March 04, 2021

Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma.

Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma.

Journal: Oncology letters

Published: July 17, 2019

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Frontiers in pharmacology

Published: February 21, 2019

Exploratory analysis of introducing next-generation sequencing-based method to treatment-naive lung cancer patients.

Exploratory analysis of introducing next-generation sequencing-based method to treatment-naive lung cancer patients.

Journal: Journal of thoracic disease

Published: December 04, 2018

Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Journal: Thoracic cancer

Published: October 09, 2017

Amoxicillin and clavulanate potassium in treating children with suppurative tonsillitis.

Amoxicillin and clavulanate potassium in treating children with suppurative tonsillitis.

Journal: Journal of biological regulators and homeostatic agents

Published: September 28, 2017

Value of multi-slice spiral CT in preoperative diagnosis of pancreatic cancer

Value of multi-slice spiral CT in preoperative diagnosis of pancreatic cancer

Journal: Zhonghua yi xue za zhi

Published: March 30, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026